AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 223 filers reported holding AXSOME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,760,851 | +228.2% | 53,811 | +237.5% | 0.13% | +214.3% |
| Q2 2023 | $1,145,880 | -70.2% | 15,946 | -74.4% | 0.04% | -73.1% |
| Q1 2023 | $3,845,810 | +1747.4% | 62,351 | +2210.2% | 0.16% | +1460.0% |
| Q4 2022 | $208,174 | -94.0% | 2,699 | -92.0% | 0.01% | -96.0% |
| Q4 2019 | $3,489,000 | +141.6% | 33,753 | -52.7% | 0.25% | +131.5% |
| Q3 2019 | $1,444,000 | -24.9% | 71,377 | -4.4% | 0.11% | -18.8% |
| Q2 2019 | $1,923,000 | -23.6% | 74,678 | -57.8% | 0.13% | -6.3% |
| Q1 2019 | $2,518,000 | – | 176,973 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |